Topiramate induced histopathological changes in placenta of rats

Indian Journal of Experimental Biology

Volumn 46, Issue 10, 2008, Pages 715-719

  Mishra, A ^a,b   Singh, M ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b Rohilkhand Medical College   (India)

Author keywords

Decidua basalis; Fibrinoid matter; Gestation day; Giant cells; Glycolysis; Mesenchyme

Indexed keywords

RATTUS;

ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE; TOPIRAMATE;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; GESTATIONAL AGE; PATHOLOGY; PLACENTA; PREGNANCY; RAT;

ANIMALS; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FRUCTOSE; GESTATIONAL AGE; PLACENTA; PREGNANCY; RATS;

EID: 58149373723     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Delgado-Escueta, A V & Janz D, Consensus guidelines: preconception counseling, management and care of pregnant women with epilepsy, Neurology, 42(1992) 149.
2. Wasserstein A G, Rak I & Rufe R F, Nephrolithiasis during treatment with topiramate, Epilepsia, 3 (1993) 153.
3. Singh M & Mishra A, Prenatal topiramate exposure induced developmental changes in rat brain, Annals of Neurosciences, 12 (2005)16.
4. Garnett W R, Clinical pharmacology of topiramate, Epilepsia, 41 (2002) 61.
5. Pavuluri M N, Janicak P G & Carbray J, Topiramate plus resperidone for controlling weight gain and symptoms in preschool mania, Jr Child Adol Psychopharmacol, 12 (2002) 271.
6. Benirshke K & Driscoll S G, The pathology of the human placenta, (Springer, New York) 1967.
7. Boyd J D & Hamilton W J, The Human Placenta, (Heffer, Cambridge) 1970.
8. Padmanabhan R & Singh S, Histopathological changes of placenta induced by Cyclophosphamide in mice, Cong anom, 20 (1980) 365.
9. Pacifici G M & Nottoli R, Placental transfer of drugs administered to the mother, Clin Pharmacokinet, 28 (1995) 235.
10. Marin J J, Briz O & Serrano M A, A review on the molecular mechanisms involved in the placental barrier for drugs, Curr Drug Deliv, 1 (2004) 275.
11. Syme M R, Paxton J W & Keelan J A, Drug transfer and metabolism by the human placenta, Clin Pharmacokinet, 43 (2004) 487.
12. Morrel M J, Guidelines for the care of women with epilepsy, Neurology, 4 (1998) 21.
13. Hoyme H E, Hauck L & Quinn D, Minor anomalies accompanying prenatal exposure to topiramate, Epilepsia, 1 (1998) 119.
14. Glauser T A, Topiramate, Epilepsia, 5 (1999) 71.
15. 3- exchange, Br J Pharmacol, 142 (2004) 831.
16. Pennel P B, Antiepileptic drug pharmacokinetics during pregnancy and lactation, Neurology, 6 (2003) 35.
17. Hoover R C, Motta M & Danis J, Differential effects of the anticonvulsant topiramate on neuro behavioural and histological outcomes following traumatic brain injury in rats, J Neurotrau 21 (2004) 501.
18. Wu S P, Mubner J B & Streeter A J, Evaluation of the absorption, excretion, pharmacokinetics and metabolism of the anticonvulsant topiramate in healthy men, Pharm Res, 11 (1994) 336.
19. Wu S P, Shyu M K & Liou H H, Interaction between anticonvulsants and human placental Cartinine Tranporter, Epilepsia, 45 (2004) 204.